Inter Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Inter Pharma has a total shareholder equity of THB2.1B and total debt of THB304.0M, which brings its debt-to-equity ratio to 14.2%. Its total assets and total liabilities are THB3.0B and THB847.3M respectively. Inter Pharma's EBIT is THB41.3M making its interest coverage ratio 2.2. It has cash and short-term investments of THB219.3M.
Key information
14.2%
Debt to equity ratio
฿303.99m
Debt
| Interest coverage ratio | 2.2x |
| Cash | ฿219.32m |
| Equity | ฿2.14b |
| Total liabilities | ฿847.31m |
| Total assets | ฿2.99b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IP-R's short term assets (THB981.5M) exceed its short term liabilities (THB482.8M).
Long Term Liabilities: IP-R's short term assets (THB981.5M) exceed its long term liabilities (THB364.5M).
Debt to Equity History and Analysis
Debt Level: IP-R's net debt to equity ratio (4%) is considered satisfactory.
Reducing Debt: IP-R's debt to equity ratio has increased from 13.3% to 14.2% over the past 5 years.
Debt Coverage: IP-R's debt is well covered by operating cash flow (62.1%).
Interest Coverage: IP-R's interest payments on its debt are not well covered by EBIT (2.2x coverage).